Clinical Trial Update: A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and tolerability of OM-85-IN in healthy volunteers and patients with mild allergic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• OM-85-IN

Snippet

Sponsor: OM Pharma SA | Conditions: Allergic Asthma | Phase 1 | Status: COMPLETED